Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results
An Innovative and Linguistically-Tailored Mobile Intervention to Improve Follow-Up for Abnormal Pap Test Results: CervixChat
2 other identifiers
interventional
30
1 country
1
Brief Summary
This clinical trial evaluates the feasibility of a linguistically-tailored mobile intervention, called CervixChat in improving the follow-up of patients with abnormal Papanicolaou (pap) test results. A text messaging program, such as CervixChat may support patients who need a colposcopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 18, 2021
CompletedFirst Submitted
Initial submission to the registry
March 26, 2021
CompletedFirst Posted
Study publicly available on registry
March 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2021
CompletedApril 29, 2025
April 1, 2025
6 months
March 26, 2021
April 28, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Patient Consent Rate
Up to 12 months
Study Completion Rate
Up to 12 months
Study Arms (1)
Supportive care (message)
EXPERIMENTALPatients receive text messages for 1-2 months before scheduled appointment. Patients also complete a survey at baseline and after standard of care colposcopy and an interview after standard of care colposcopy.
Interventions
Eligibility Criteria
You may qualify if:
- Female, aged 21 to 65 years of age
- Had received an abnormal Pap smear result
- Scheduled colposcopy
- Able to communicate with ease in English or Spanish
- Have a cell phone with text (TXT) ability
- Competent to give consent
You may not qualify if:
- Are pregnant at the time of recruitment
- Display current evidence of positive invasive carcinoma of the cervix
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2021
First Posted
March 29, 2021
Study Start
February 18, 2021
Primary Completion
August 31, 2021
Study Completion
September 10, 2021
Last Updated
April 29, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share